We design, prototype, and orchestrate AI applications that deliver measurable impact on sales productivity, marketing outcomes, and strategic decisions.
Forty five minutes with the founder. Complimentary.
They do not know:
We build AI that carries 25 years of pharma commercial expertise, so the recommendations make sense to the people who must act on them.
We build working AI prototypes that prove value before you scale, combining deep pharma expertise with practical AI implementation.
We combine 25+ years of pharma domain expertise with AI strategy to identify and validate your highest value opportunities. Our sweet spot is taking you from problem identification to a working prototype that proves real business impact.
We take on work only where the value clearly outweighs the cost. Every use case is directly tied to revenue growth or cost reduction.
Our proof of concept process validates value before scale up. We share our approach and anonymized proof points during discovery calls.
We understand doctor engagement, the competitive market environment, and field force realities.
See working prototypes fast, not months of planning.
What we do:
What you get:
What we do:
What you get:
Your options:
What you get:
A system that reads your secondary sales, call data, and RCPA inputs together, and shows which territories are declining despite full field effort, and where the next call is worth more.
A system that connects brand campaign, digital, and promotional spend to prescription movement at brand and geography level, so the next cycle's money follows evidence.
A system that keeps your launch and portfolio assumptions under continuous watch against your own market data, so course corrections come early instead of at year end.
These are illustrations, not a fixed list. Every build starts from your problem, your data, and your workflows.
AI in pharma commercial work has moved from experiment to daily use. The companies gaining from it are the ones that started small, proved value on one workflow, and grew from there. A two week discovery is a low risk way to find out where it pays in your business.
Field costs rise every year. Pharma companies need higher productivity from existing resources. AI is the most practical way to achieve this without a proportional cost increase.
AI has moved from experimental to essential. AI models now deliver consistent, measurable results in pharma applications.
Unlike traditional IT projects, AI prototypes show value in weeks. You see the indicative value before making major investments.
Tech vendors build what you ask for. We identify what will actually drive revenue, prove it works, then help you build it right.
Absolutely. We provide complete specifications and knowledge transfer, so your internal IT team can carry the build forward with our guidance.
You only pay for the discovery phase. There is no obligation to proceed if value is not proven during the proof of concept.
Book a discovery call to explore where custom AI can drive revenue growth in your pharma business.